{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:17:24Z","timestamp":1790702244304,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cidjournal.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.clindermatol.2016.10.010","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T08:31:09Z","timestamp":1477557069000},"page":"173-178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Topical treatments for acne"],"prefix":"10.1016","volume":"35","author":[{"given":"Marita","family":"Kosmadaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Katsambas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2016.10.010_bb0005","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1111\/jdv.13776","article-title":"European evidence-based (S3) guideline for the treatment of acne-update 2016-short version","volume":"30","author":"Nast","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/IAI.35.1.71-78.1982","article-title":"Neutrophil chemotaxis by Propionibacterium acnes lipase and its inhibition","volume":"35","author":"Lee","year":"1982","journal-title":"Infect immun"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0015","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000017846","article-title":"An overview of topical antibiotics for acne treatment","volume":"196","author":"Toyoda","year":"1998","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0020","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1365-2133.1990.tb08270.x","article-title":"Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients","volume":"122","author":"Eady","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0025","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1365-2133.2005.06614.x","article-title":"Treatment of acne with topical antibiotics: lessons from clinical studies","volume":"153","author":"Simonart","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0030","first-page":"71","article-title":"Topical clindamycin versus oral tetracycline and placebo in acne vulgaris","volume":"43","author":"Braathen","year":"1984","journal-title":"Scand J Infect Dis Suppl"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0035","first-page":"424","article-title":"Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg\/day in the treatment of acne vulgaris","volume":"26","author":"Stoughton","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0040","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/j.1365-2133.1987.tb05853.x","article-title":"Topical clindamycin phosphate compared with oral tetracycline in the treatment of acne vulgaris","volume":"116","author":"Katsambas","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.2340\/00015555-70534537","article-title":"A double-blind comparison of topical clindamycin and oral minocycline in the treatment of acne vulgaris","volume":"70","author":"Sheehan-Dare","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0050","first-page":"593","article-title":"Antibiotic resistant acne","volume":"17","author":"Leyden","year":"1976","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0055","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S1473-3099(15)00527-7","article-title":"Systematic review of antibiotic resistance in acne: an increasing topical and oral threat","volume":"16","author":"Walsh","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0060","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/j.1365-2133.1992.tb00104.x","article-title":"Antibiotic resistance patterns in coagulase-negative staphylococci after treatment with topical erythromycin, benzoyl peroxide, and combination therapy","volume":"126","author":"Harkaway","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0065","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/000155502320323216","article-title":"Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle","volume":"82","author":"Mills","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0070","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/jid.2011.182","article-title":"Microbial symbiosis with the innate immune defense system of the skin","volume":"131","author":"Gallo","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0075","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1001\/archderm.139.4.467","article-title":"Effect of antibiotics on the oropharyngeal flora in patients with acne","volume":"139","author":"Levy","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0080","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/archderm.141.9.1132","article-title":"Antibiotic treatment of acne may be associated with upper respiratory tract infections","volume":"141","author":"Margolis","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0085","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-4362.1979.tb01956.x","article-title":"The combined use of topical benzoyl peroxide and tretinoin in the treatment of acne vulgaris","volume":"18","author":"Handojo","year":"1979","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0090","first-page":"607","article-title":"Clinical safety and efficacy studies of a novel formulation combining 1.2% clindamycin phosphate and 0.025% tretinoin for the treatment of acne vulgaris","volume":"6","author":"Schlessinger","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0095","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1067\/S0190-9622(03)01154-X","article-title":"A review of the use of combination therapies for the treatment of acne vulgaris","volume":"49","author":"Leyden","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0100","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1586\/17512433.2015.1046839","article-title":"Allergic contact dermatitis caused by topical antiacne drugs","volume":"8","author":"Veraldi","year":"2015","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0105","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/jac\/28.6.843","article-title":"The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37","volume":"28","author":"Bojar","year":"1991","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0110","first-page":"31","article-title":"Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne","volume":"143","author":"Cunliffe","year":"1989","journal-title":"Acta Derm Venereol Suppl"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0115","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/BF00372056","article-title":"Inhibitory effect of azelaic acid on neutrophil functions: a possible cause for its efficacy in treating pathogenetically unrelated diseases","volume":"283","author":"Akamatsu","year":"1991","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0120","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/exd.12066","article-title":"Azelaic acid reduced senescence-like phenotype in photo-irradiated human dermal fibroblasts: possible implication of PPARgamma","volume":"22","author":"Briganti","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0125","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1600-0625.2010.01107.x","article-title":"Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation","volume":"19","author":"Mastrofrancesco","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0130","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jaad.2013.05.019","article-title":"Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel","volume":"69","author":"Coda","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0135","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/1523-1747.ep12277353","article-title":"Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro","volume":"93","author":"Detmar","year":"1989","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0140","first-page":"20","article-title":"Effects of azelaic acid on sebaceous gland, sebum excretion rate and keratinization pattern in human skin. An in vivo and in vitro study","volume":"143","author":"Mayer-da-Silva","year":"1989","journal-title":"Acta Derm Venereol Suppl"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0145","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2133.1983.tb03990.x","article-title":"Beneficial effect of 15% azelaic acid cream on acne vulgaris","volume":"109","author":"Nazzaro-Porro","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0150","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/j.1365-2133.1983.tb00560.x","article-title":"The effect of azelaic acid on acne","volume":"109","author":"Marsden","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0155","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1468-3083.2006.01914.x","article-title":"Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne","volume":"21","author":"Stinco","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0160","first-page":"40","article-title":"Long-term treatment of acne with 20% azelaic acid cream","volume":"143","author":"Cavicchini","year":"1989","journal-title":"Acta Derm Venereol Suppl"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0165","first-page":"35","article-title":"Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris. Comparison with vehicle and topical tretinoin","volume":"143","author":"Katsambas","year":"1989","journal-title":"Acta Derm Venereol Suppl"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0170","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1365-2133.1995.tb05014.x","article-title":"The short-term treatment of acne vulgaris with benzoyl peroxide: effects on the surface and follicular cutaneous microflora","volume":"132","author":"Bojar","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0175","first-page":"417","article-title":"Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%","volume":"82","author":"Leyden","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0180","first-page":"90","article-title":"Benzoyl peroxide lotion (20 percent) in acne","volume":"25","author":"Smith","year":"1980","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0185","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2133.1983.tb00063.x","article-title":"Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris","volume":"108","author":"Burke","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0190","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0190-9622(97)70177-4","article-title":"Treatment of acne with a combination clindamycin\/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations","volume":"37","author":"Lookingbill","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0195","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-4362.1978.tb06072.x","article-title":"Comparative effectiveness of benzoyl peroxide and tretinoin in acne vulgaris","volume":"17","author":"Lyons","year":"1978","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0200","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1080\/09546630310007088","article-title":"Single-blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BID) and adapalene 0.1% gel (QD) in the treatment of acne vulgaris for 11 weeks","volume":"14","author":"do Nascimento","year":"2003","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0205","first-page":"1033","article-title":"The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial","volume":"12","author":"Babaeinejad","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0210","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients","volume":"59","author":"Thiboutot","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0215","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/jdv.13622","article-title":"A multicentre, randomized, single-blind comparison of topical clindamycin 1%\/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients","volume":"30","author":"Xu","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0220","first-page":"131","article-title":"A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%\/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%\/tretinoin 0.025% gel in the topical treatment of acne vulgaris","volume":"9","author":"Jackson","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0225","first-page":"44","article-title":"A new, once-daily, optimized, fixed combination of clindamycin phosphate 1.2% and low-concentration benzoyl peroxide 2.5% gel for the treatment of moderate-to-severe acne","volume":"2","author":"Gold","year":"2009","journal-title":"J Clin Aesthetic Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0230","first-page":"1382","article-title":"Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study","volume":"10","author":"Eichenfield","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0235","first-page":"1083","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris","volume":"13","author":"Pariser","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0240","first-page":"381","article-title":"The efficacy and tolerability of a fixed combination clindamycin (1.2%) and benzoyl peroxide (3.75%) aqueous gel in patients with facial acne vulgaris: gender as a clinically relevant outcome variable","volume":"14","author":"Harper","year":"2015","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0245","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/09546631003681094","article-title":"Synergistic efficacy of adapalene 0.1%-benzoyl peroxide 2.5% in the treatment of 3855 acne vulgaris patients","volume":"22","author":"Tan","year":"2011","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0250","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","article-title":"Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study","volume":"57","author":"Thiboutot","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0255","first-page":"26","article-title":"Absence of degradation of tretinoin when benzoyl peroxide is combined with an optimized formulation of tretinoin gel (0.05%)","volume":"3","author":"Del Rosso","year":"2010","journal-title":"J Clin Aesthetic Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0260","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S0190-9622(89)80098-2","article-title":"Benzoyl peroxide in acne","volume":"20","author":"Cunliffe","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0265","first-page":"41","article-title":"Mechanisms of the comedolytic and anti-inflammatory properties of topical retinoids","volume":"4","author":"Bikowski","year":"2005","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0270","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1529-8019.2006.00084.x","article-title":"Update in retinoid therapy of acne","volume":"19","author":"Thielitz","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0275","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/S0190-9622(98)70443-8","article-title":"Topical tretinoin in acne therapy","volume":"39","author":"Webster","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0280","first-page":"466","article-title":"Evaluating tretinoin formulations in the treatment of acne","volume":"13","author":"Kircik","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0285","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3109\/09546634.2012.751085","article-title":"Short contact therapy of acne with tretinoin","volume":"24","author":"Veraldi","year":"2013","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0290","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1046\/j.1365-4362.1998.00254.x","article-title":"Topical isotretinoin vs. topical retinoic acid in the treatment of acne vulgaris","volume":"37","author":"Dominguez","year":"1998","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0295","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0190-9622(88)70202-9","article-title":"Comparison of the stability of topical isotretinoin and topical tretinoin and their efficacy in acne","volume":"19","author":"Elbaum","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0300","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1046\/j.1365-2133.2002.04873.x","article-title":"Topical adapalene gel 0.1% vs. isotretinoin gel 0.05% in the treatment of acne vulgaris: a randomized open-label clinical trial","volume":"147","author":"Ioannides","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0305","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000018255","article-title":"A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris","volume":"199","author":"Glass","year":"1999","journal-title":"Dermatology"},{"issue":"suppl 52","key":"10.1016\/j.clindermatol.2016.10.010_bb0310","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1365-2133.1998.1390s2048.x","article-title":"A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials","volume":"139","author":"Cunliffe","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0315","first-page":"110","article-title":"A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Gold","year":"2009","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0320","first-page":"32","article-title":"Adapalene 0.3% for the treatment of acne in women","volume":"6","author":"Berson","year":"2013","journal-title":"J Clin Aesthetic Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0325","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/jocd.12031","article-title":"Efficacy and safety of adapalene gel 0.1% and 0.3% and tretinoin gel 0.05% for acne vulgaris: results of a single-center, randomized, double-blinded, placebo-controlled clinical trial on Mexican patients (skin type III-IV)","volume":"12","author":"Tirado-Sanchez","year":"2013","journal-title":"J Cosmetic Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0330","first-page":"12","article-title":"Once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.1% microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial","volume":"69","author":"Leyden","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0335","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/14764170410032406","article-title":"Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study","volume":"6","author":"Lowe","year":"2004","journal-title":"J Cosmetic Laser Ther"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0340","first-page":"4","article-title":"A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris","volume":"69","author":"Webster","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0345","first-page":"549","article-title":"Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris","volume":"9","author":"Tanghetti","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0350","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/archderm.138.4.481","article-title":"Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel","volume":"138","author":"Bershad","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0355","first-page":"20","article-title":"Tazarotene combination leads to efficacious acne results trial study G. Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy","volume":"69","author":"Draelos","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0360","first-page":"256","article-title":"Tazarotene versus tazarotene plus clindamycin\/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial","volume":"5","author":"Tanghetti","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0365","first-page":"981","article-title":"Dapsone gel 5% for the treatment of acne vulgaris: safety and efficacy of long-term (1 year) treatment","volume":"6","author":"Lucky","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0370","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2006.10.005","article-title":"Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris","volume":"56","author":"Draelos","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0375","first-page":"553","article-title":"Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: first of two identically designed, large, multicenter, randomized, vehicle-controlled trials","volume":"15","author":"Stein Gold","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0380","first-page":"962","article-title":"Efficacy and safety of once-daily dapsone gel, 7.5% for treatment of adolescents and adults with acne vulgaris: second of two identically designed, large, multicenter, randomized, vehicle-controlled trials","volume":"15","author":"Eichenfield","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0385","first-page":"1417","article-title":"The efficacy and tolerability of dapsone 5% gel in female vs male patients with facial acne vulgaris: gender as a clinically relevant outcome variable","volume":"11","author":"Tanghetti","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0390","first-page":"31","article-title":"Comparative efficacy and tolerability of dapsone 5% gel in adult versus adolescent females with acne vulgaris","volume":"8","author":"Del Rosso","year":"2015","journal-title":"J Clin Aesthetic Dermatol"},{"key":"10.1016\/j.clindermatol.2016.10.010_bb0395","first-page":"191","article-title":"Use of dapsone 5% gel as maintenance treatment of acne vulgaris following completion of oral doxycycline and dapsone 5% gel combination treatment","volume":"15","author":"Kircik","year":"2016","journal-title":"J Drugs Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X16302711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T06:17:53Z","timestamp":1718864273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X16302711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0738081X16302711"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.010","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical treatments for acne","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2016.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}